Blood Products

IVIG with Four Viral Removal/Inactivation Steps Introduced

Published in AIDS Weekly, March 10th, 1997

Bayer Corp., West Haven, Connecticut, announced the introduction of Gamimune N as the first Intravenous Immune Globulin (IVIG) with four validated viral removal/inactivation steps.

Originally introduced in 1986, Gamimune N has continuously maintained a safety record of no documented cases of viral transmission in more than 1.9 million calculated doses.

The use of solvent/detergent treatment provides an additional safety step in Gamimune N's plasma viral removal/inactivation process. The announcement was made at the joint meeting of the American Academy of Allergy, Asthma, and Immunology, the American Association of Immunologists, and the Clinical...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1997-03-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry